Annotated Medicine and Device Lists

Carbamazepine

N/A Oral liquid 100 mg/5 ml Oral liquid 20 mg/ml Suspension 2% x 100 ml Suspension 100 mg/5 ml Suspension 2% (100 mg/ 5 ml) Syu 100 mg/5 ml Tablet 100 mg Tablet 400mg Tablet 200 mg Tablet (chewable) 100 mg Tablet (chewable) 200 mg Tablet (scored) 100 mg Tablet (scored) 200 mg

This medicine is present in:

List	Section	Observation
Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016	Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC	Others observations: INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS SALVO: FORMAS FARMACÉUTICAS QUE MODIFICAN LA LIBERACIÓN DEL PRINCIPIO ACTIVO
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018	05.05. FÁRMACOS PARA EL DOLOR NEUROPÁTICO	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines 2019	05. Anticonvulsants/antiepileptics	No observations
PAHO Strategic Fund Medicine List	12.1. Oxytocics	Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Peru	05. Anticonvulsants/Antiepileptics	No observations
Paraguay. Lista de Medicamentos Esenciales. 2009	03. ANTIEPILÉPTICOS	No observations

This medicine is present in:

List	Section	Observation
Brasil. Relação Nacional de Medicamentos Essenciais. 2020	N. SISTEMA NERVOSO	No observations

This medicine is present in:

List	Section	Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health.	Cns Anticonvulsants-Miscellaneous	No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019	28. Anticonvulsivos	No observations

This medicine is present in:

List	Section	Observation
Mexico. Cuadro Basico de Medicamentos - 2017	14. NEUROLOGIA	No observations

This medicine is present in:

List	Section	Observation
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020	03 ANTIEPILÉPTICOS	No observations

This medicine is present in:

List	Section	Observation
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015	02.01 ANTICONVULSANTS	No observations

This medicine is present in:

List	Section	Observation
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015	02.01 ANTICONVULSANTS	No observations

This medicine is present in:

List	Section	Observation
Ecuador	Essential Medicines List - Ecuador	No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015	02.01 ANTICONVULSANTS	No observations
Mexico. Cuadro Basico de Medicamentos - 2017	14. NEUROLOGIA	No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020	N. SISTEMA NERVOSO	No observations

This medicine is present in:

List	Section	Observation
Ecuador	Essential Medicines List - Ecuador	No observations
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health.	Cns Anticonvulsants-Miscellaneous	No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública.	CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública.	Others observations: X 90 TABLETAS.
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020	03 ANTIEPILÉPTICOS	No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019	28. Anticonvulsivos	No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015	02.01 ANTICONVULSANTS	No observations
Mexico. Cuadro Basico de Medicamentos - 2017	14. NEUROLOGIA	No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020	N. SISTEMA NERVOSO	No observations
Paraguay. Lista de Medicamentos Esenciales. 2009	03. ANTIEPILÉPTICOS	No observations
El Salvador - 2019	ANTIEPILÉPTICOS	No observations
Chile. Formulario Nacional de Medicamentos. 2005	05. ANTICONVULSIVANTES Y ANTIEPILÉPTICOS	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines 2019	05. Anticonvulsants/antiepileptics	No observations
PAHO Strategic Fund Medicine List	12.1. Oxytocics	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines 2019	05. Anticonvulsants/antiepileptics	No observations
PAHO Strategic Fund Medicine List	12.1. Oxytocics	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines 2019	05. Anticonvulsants/antiepileptics	No observations
WHO Model List of Essential Medicines 2019	24.2.2. Medicines used in bipolar disorders	No observations
PAHO Strategic Fund Medicine List	12.1. Oxytocics	Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines 2019	05. Anticonvulsants/antiepileptics	No observations
WHO Model List of Essential Medicines 2019	24.2.2. Medicines used in bipolar disorders	No observations
PAHO Strategic Fund Medicine List	12.1. Oxytocics	Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Peru	05. Anticonvulsants/Antiepileptics	No observations
Peru	24.2.2 For Bipolar Disorder	No observations

Information Resources: Carbamazepine

No information available